Joel H. Kaufman

2018

In 2018, Joel H. Kaufman earned a total compensation of $313.4K as Chief Business Officer at Navidea Biopharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$78,751
Option Awards$5,176
Salary$225,000
Other$4,493
Total$313,420

Kaufman received $225K in salary, accounting for 72% of the total pay in 2018.

Kaufman also received $78.8K in non-equity incentive plan, $5.2K in option awards and $4.5K in other compensation.

Rankings

In 2018, Joel H. Kaufman's compensation ranked 13,070th out of 14,244 executives tracked by ExecPay. In other words, Kaufman earned more than 8.2% of executives.

ClassificationRankingPercentile
All
13,070
out of 14,244
8th
Division
Manufacturing
5,295
out of 5,765
8th
Major group
Chemicals And Allied Products
1,981
out of 2,128
7th
Industry group
Drugs
1,700
out of 1,817
6th
Industry
In Vitro and In Vivo Diagnostic Substances
62
out of 72
14th
Source: SEC filing on August 2, 2021.

Kaufman's colleagues

We found four more compensation records of executives who worked with Joel H. Kaufman at Navidea Biopharmaceuticals in 2018.

2018

Michael Goldberg

Navidea Biopharmaceuticals

Chief Executive Officer

2018

Jed Latkin

Navidea Biopharmaceuticals

Chief Executive Officer

2018

Frederick Cope

Navidea Biopharmaceuticals

Chief Scientific Officer

2018

Michael Rosol

Navidea Biopharmaceuticals

Chief Medical Officer

News

You may also like